MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy

Diabetes

Volumn 60, Issue 4, 2011, Pages 1314-1323

  McArthur, Kara ^a   Feng, Biao ^a   Wu, Yuexiu ^a   Chen, Shali ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MICRORNA; MICRORNA 200B; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EMBRYO; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION PROFILING; GENE LOCATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NONHUMAN; PERMEABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RETINA CAPILLARY; RETINA CELL; RNA ANALYSIS; STREPTOZOCIN DIABETES;

3' UNTRANSLATED REGIONS; ANIMALS; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953225170     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1557     Document Type: Article

References (44)

1. Khan ZA, Farhangkhoee H, Chakrabarti S. Towards newer molecular targets for chronic diabetic complications. Curr Vasc Pharmacol 2006;4:45-57 (Pubitemid 46785181)
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820 (Pubitemid 34000785)
3. Chuang JC, Jones PA. Epigenetics and microRNAs. Pediatr Res 2007;61:24R-29R
4. Latronico MV, Catalucci D, Condorelli G. MicroRNA and cardiac pathologies. Physiol Genomics 2008;34:239-242 (Pubitemid 352758839)
5. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 2005;7:719-723 (Pubitemid 40975754)
6. Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006;38:228-233 (Pubitemid 43177239)
7. Khan ZA, Chakrabarti S. Growth factors in proliferative diabetic retinopathy. Exp Diabesity Res 2003;4:287-301 (Pubitemid 38035568)
8. Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res 1997;29:354-362 (Pubitemid 27427368)
9. Magnussen AL, Rennel ES, Hua J, et al. VEGF-A165b is cytoprotective and anti-angiogenic in the retina. Invest Ophthalmol Vis Sci 2010;51:4273-4281
10. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 2006;39:469-478 (Pubitemid 44714526)
11. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995;376:62-66
12. Chen S, Feng B, George B, Chakrabarti R, Chen M, Chakrabarti S. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am J Physiol Endocrinol Metab 2010;298:E127-E137
13. Chiu J, Khan ZA, Farhangkhoee H, Chakrabarti S. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition 2009;25:964-972
14. Kaur H, Chen S, Xin X, Chiu J, Khan ZA, Chakrabarti S. Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300. Diabetes 2006;55:3104-3111 (Pubitemid 44923649)
15. Miller EC, Capps BE, Sanghani RR, Clemmons DR, Maile LA. Regulation of igf-I signaling in retinal endothelial cells by hyperglycemia. Invest Ophthalmol Vis Sci 2007;48:3878-3887 (Pubitemid 351261130)
16. Maile LA, Allen LB, Veluvolu U, et al. Identification of compounds that inhibit IGF-I signaling in hyperglycemia . Exp Diabetes Res 2009;2009:267107
17. van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006;103:18255-18260 (Pubitemid 44871645)
18. Feng B, Chen S, George B, Feng Q, Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 2010;26:40-49
19. Chen S, Apostolova MD, Cherian MG, Chakrabarti S. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Invest 2000;80:1311-1321 (Pubitemid 30637071)
20. Khan ZA, Chan BM, Uniyal S, et al. EDB fibronectin and angiogenesis - a novel mechanistic pathway. Angiogenesis 2005;8:183-196 (Pubitemid 41759143)
21. Cukiernik M, Hileeto D, Evans T, Mukherjee S, Downey D, Chakrabarti S. Vascular endothelial growth factor in diabetes induced early retinal abnormalities. Diabetes Res Clin Pract 2004;65:197-208 (Pubitemid 39141175)
22. Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas. Diabetes 2008;57:1026-1033
23. Wang M, Tan LP, Dijkstra MK, et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 2008;215:13-20 (Pubitemid 351619871)
24. Chen S, Mukherjee S, Chakraborty C, Chakrabarti S. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol Cell Physiol 2003;284:C263-C272 (Pubitemid 36120064)
25. Li Y, Wu H, Khardori R, Song YH, Lu YW, Geng YJ. Insulin-like growth factor-1 receptor activation prevents high glucose-induced mitochondrial dysfunction, cytochrome-c release and apoptosis. Biochem Biophys Res Commun 2009;384:259-264
26. Adam L, Zhong M, Choi W, et al. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 2009;15:5060-5072
27. Li Y, VandenBoom TG 2nd, Kong D, et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res 2009;69:6704-6712
28. Mees ST, Mardin WA, Wendel C, et al. EP300 - a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer 2010;126:114-124
29. Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007;104:3432-3437 (Pubitemid 46364176)
30. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010;21:438-447
31. Wang B, Koh P, Winbanks C, et al. miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes 2011;60:280-287
32. King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004;122:333-338 (Pubitemid 39506591)
33. Bausero P, Cavaillé F, Méduri G, Freitas S, Perrot-Applanat M. Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis 1998;2:167-182 (Pubitemid 128511984)
34. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 1997;100(Suppl.):S7-S10 (Pubitemid 28009538)
35. Jackson MW, Roberts JS, Heckford SE, et al. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res 2002;62:854-859 (Pubitemid 34126964)
36. Kevil CG, Payne DK, Mire E, Alexander JS. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 1998;273:15099-15103 (Pubitemid 28272806)
37. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-233
38. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-531 (Pubitemid 38868508)
39. Arora A, McKay GJ, Simpson DA. Prediction and verification of miRNA expression in human and rat retinas. Invest Ophthalmol Vis Sci 2007;48:3962-3967
40. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 2005;280:9330-9335 (Pubitemid 40409626)
41. Otsuka M, Zheng M, Hayashi M, et al. Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J Clin Invest 2008;118:1944-1954 (Pubitemid 351632396)
42. Shen J, Yang X, Xie B, et al. MicroRNAs regulate ocular neovascularization. Mol Ther 2008;16:1208-1216 (Pubitemid 351866051)
43. Hu X, Macdonald DM, Huettner PC, et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol 2009;114:457-464
44. Tang X, Tang G, Ozcan S. Role of microRNAs in diabetes. Biochem Biophys Acta 2008;114:897-701